Neurofibromatosis type 1
- Synonyms
- NF1, von Recklinghausen disease
- Specialty
- Dermatology · Hereditary skin diseases
- Images
- Clinical 4 · Histology 4
- In the app
- 5 flashcards
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (8)


Histology
Histology
Histology
Histology

Definition
Neurofibromatosis type 1 (von Recklinghausen disease) is an autosomal dominant tumour predisposition syndrome caused by mutations in the NF1 gene, which encodes neurofibromin. It occurs in about 1 in 3000 births.
- Genetics: NF1 gene (Neurofibromin) — RAS-GAP inactivation, AD, 50% new mutations.
- Skin Manifestations: Nevus anemicus, Buttonhole sign (inducible fibromas), Wattle-like masses (large spongy NFs), Glomus tumors of the fingers.
- Risks: CML risk, MPNST risk ~10%, learning disability / ADHD, scoliosis.
Clinical features
- Café-au-lait macules: six or more well-defined light brown patches over 0.5 cm in diameter before puberty or over 1.5 cm after puberty; they may be present at birth and increase in number during the first years of life.
- Freckling in the axillae and groins (Crowe sign), typically appearing at puberty – after the café-au-lait macules and before the neurofibromas.
- Neurofibromas: cutaneous (soft, button-like nodules that invaginate on pressure) and subcutaneous neurofibromas, and plexiform neurofibromas (bag-like masses), which occur only in NF1 and can become malignant.
- Lisch nodules of the iris (in 97–100% after puberty), optic gliomas, bone changes (malformation of long bones, pseudarthrosis, sphenoid wing dysplasia, scoliosis), learning difficulties (25–40%).
Diagnosis
- Clinical diagnosis based on the typical features (café-au-lait macules, freckling in skin folds, neurofibromas, Lisch nodules) and family history.
- Ophthalmological examination (Lisch nodules, optic glioma), molecular genetic testing of NF1 in unclear cases.
Differential diagnoses
- Tuberous sclerosis
- Café-au-lait Spots
- Piebaldism
- Naevus depigmentosus (achromic naevus)
Image credits for the thumbnails
- Becker naevus (Becker melanosis): Siller, “Becker-Naevus”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Oculocutaneous albinism: Janjacob, “Albino boy by JJ Hoefnagel”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
Treatment principles
- There is no causal treatment; interdisciplinary follow-up is central, including ophthalmological (optic glioma), neurological and developmental assessment and blood pressure monitoring.
- Bothersome cutaneous neurofibromas can be excised or treated with laser; symptomatic, inoperable plexiform neurofibromas can be treated with targeted MEK inhibitors.
- Painful or rapidly growing plexiform tumours must be investigated for malignant transformation; genetic counselling is part of management.
Specific treatment regimens with drugs and doses are covered in the DermaFuchs app.
Keep learning in the app
References (selection)
Cross-references
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the DermaFuchs app – free, in your browser or as an app.
Related pages: Tuberous sclerosis · Becker naevus (Becker melanosis) · Oculocutaneous albinism
Note: This page is intended for medical education and does not replace diagnosis or treatment decisions in individual cases.

